151 related articles for article (PubMed ID: 22344547)
21. Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains.
Cheedarla N; Hemalatha B; Anangi B; Muthuramalingam K; Selvachithiram M; Sathyamurthi P; Kailasam N; Varadarajan R; Swaminathan S; Tripathy SP; Vaniambadi SK; Vadakkupattu DR; Hanna LE
Front Immunol; 2018; 9():618. PubMed ID: 29662494
[TBL] [Abstract][Full Text] [Related]
22. Epitope specificity of cross-clade neutralizing sera from Chinese HIV-1-positive individuals.
Song H; Chu Y; Zhang H; Wang X; Zhang T; Qiu M; Wu H; Wu Z
Scand J Immunol; 2013 Oct; 78(4):357-70. PubMed ID: 23808939
[TBL] [Abstract][Full Text] [Related]
23. Antibodies that cross-neutralize the tier-2 pseudoviruses are produced in antiretroviral-naïve HIV-1-infected children from northern India.
Prakash SS; Andrabi R; Kumar R; Lodha R; Kabra SK; Vajpayee M; Luthra K
Arch Virol; 2012 Sep; 157(9):1797-801. PubMed ID: 22674340
[TBL] [Abstract][Full Text] [Related]
24. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.
Björling E; Scarlatti G; von Gegerfelt A; Albert J; Biberfeld G; Chiodi F; Norrby E; Fenyö EM
Virology; 1993 Mar; 193(1):528-30. PubMed ID: 8438591
[TBL] [Abstract][Full Text] [Related]
25. Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals.
Cheedarla N; Precilla KL; Babu H; Vijayan KKV; Ashokkumar M; Chandrasekaran P; Kailasam N; Sundaramurthi JC; Swaminathan S; Buddolla V; Vaniambadi SK; Ramanathan VD; Hanna LE
Sci Rep; 2017 Apr; 7():46557. PubMed ID: 28436427
[TBL] [Abstract][Full Text] [Related]
26. Broadly Neutralizing Antibody Responses in a Subset of HIV-1-Infected Individuals in Chennai, India.
Hussain SI; Panneerselvam N; Solomon S; Solomon SS; Adam K; Chandrasekaran E; Montefiori DC; Pachamuthu B
J Int Assoc Provid AIDS Care; 2017; 16(2):201-208. PubMed ID: 23422744
[TBL] [Abstract][Full Text] [Related]
27. Serum neutralizing activities from a Beijing homosexual male cohort infected with different subtypes of HIV-1 in China.
Zhang M; Jiao Y; Wang S; Zhang L; Huang Z; Chen Y; Wu H
PLoS One; 2012; 7(10):e47548. PubMed ID: 23094060
[TBL] [Abstract][Full Text] [Related]
28. Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop.
Moore PL; Gray ES; Sheward D; Madiga M; Ranchobe N; Lai Z; Honnen WJ; Nonyane M; Tumba N; Hermanus T; Sibeko S; Mlisana K; Abdool Karim SS; Williamson C; Pinter A; Morris L;
J Virol; 2011 Apr; 85(7):3128-41. PubMed ID: 21270156
[TBL] [Abstract][Full Text] [Related]
29. Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremia.
Medina-Ramírez M; Sánchez-Merino V; Sánchez-Palomino S; Merino-Mansilla A; Ferreira CB; Pérez I; González N; Alvarez A; Alcocer-González JM; García F; Gatell JM; Alcamí J; Yuste E
J Virol; 2011 Jun; 85(12):5804-13. PubMed ID: 21471239
[TBL] [Abstract][Full Text] [Related]
30. Optimization and proficiency testing of a pseudovirus-based assay for detection of HIV-1 neutralizing antibody in China.
Nie J; Wang W; Wen Z; Song A; Hong K; Lu S; Zhong P; Xu J; Kong W; Li J; Shang H; Ling H; Ruan L; Wang Y
J Virol Methods; 2012 Nov; 185(2):267-75. PubMed ID: 22796285
[TBL] [Abstract][Full Text] [Related]
31. Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.
Moore PL; Sheward D; Nonyane M; Ranchobe N; Hermanus T; Gray ES; Abdool Karim SS; Williamson C; Morris L
J Virol; 2013 May; 87(9):4882-94. PubMed ID: 23408621
[TBL] [Abstract][Full Text] [Related]
32. Cross-neutralizing antibodies to HIV-1ANT70 and HIV-1IIIB in sera of African and Belgian HIV-1-infected individuals.
Nkengasong JN; Peeters M; Ndumbe P; Janssens W; Willems B; Fransen K; Ngolle M; Piot P; van der Groen G
AIDS; 1994 Aug; 8(8):1089-96. PubMed ID: 7986404
[TBL] [Abstract][Full Text] [Related]
33. CRF01_AE-specific neutralizing activity observed in plasma derived from HIV-1-infected Thai patients residing in northern Thailand: comparison of neutralizing breadth and potency between plasma derived from rapid and slow progressors.
Sapsutthipas S; Tsuchiya N; Pathipavanich P; Ariyoshi K; Sawanpanyalert P; Takeda N; Isarangkura-na-ayuthaya P; Kameoka M
PLoS One; 2013; 8(1):e53920. PubMed ID: 23308290
[TBL] [Abstract][Full Text] [Related]
34. Cross-group neutralization of HIV-1 and evidence for conservation of the PG9/PG16 epitopes within divergent groups.
Braibant M; Gong EY; Plantier JC; Moreau T; Alessandri E; Simon F; Barin F
AIDS; 2013 May; 27(8):1239-44. PubMed ID: 23343910
[TBL] [Abstract][Full Text] [Related]
35. Cross-neutralizing antibody profile of Chinese HIV-1-infected individuals and the viral envelope features from elite neutralizers.
Ren C; Liu S; Li Y; Zhuang M; Yu H; Wang J; Sun F; Li D; Zhang H; Liu W; Liang S; Zhong P; Ling H
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):472-80. PubMed ID: 25202919
[TBL] [Abstract][Full Text] [Related]
36. Expression and characterization of HIV type 1 envelope protein associated with a broadly reactive neutralizing antibody response.
Quinnan GV; Zhang PF; Fu DW; Dong M; Alter HJ
AIDS Res Hum Retroviruses; 1999 Apr; 15(6):561-70. PubMed ID: 10221533
[TBL] [Abstract][Full Text] [Related]
37. Glycan-Dependent Neutralizing Antibodies Are Frequently Elicited in Individuals Chronically Infected with HIV-1 Clade B or C.
Cohen YZ; Lavine CL; Miller CA; Garrity J; Carey BR; Seaman MS
AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1192-201. PubMed ID: 26149894
[TBL] [Abstract][Full Text] [Related]
38. Detection of Neutralizing Antibodies in HIV-1 Patients on Antiretroviral Treatment for Over Ten Years.
Cao W; Wang X; Li B; Lin L; Du Z; Zhao H; Zhang Y; Xu Z; Qiao Y
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307159
[TBL] [Abstract][Full Text] [Related]
39. Cross-neutralizing antibodies against HIV-1 (HTLV-IIIB and HTLV-IIIRF) and HIV-2 (SBL-6669 and a new isolate SBL-K135).
Böttiger B; Karlsson A; Andreasson PA; Naucler A; Costa CM; Biberfeld G
AIDS Res Hum Retroviruses; 1989 Oct; 5(5):525-33. PubMed ID: 2590556
[TBL] [Abstract][Full Text] [Related]
40. Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections.
Rodriguez SK; Sarr AD; MacNeil A; Thakore-Meloni S; Gueye-Ndiaye A; Traoré I; Dia MC; Mboup S; Kanki PJ
J Virol; 2007 May; 81(10):5331-8. PubMed ID: 17301136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
